Bionaturis Group

August Newsletter

Let’s read Bionaturis Group latest news

IN THIS ISSUE

Biobide takes part in a research about Malaria funded by Melinda and Bill Gates

Biotechnology private investment increases

Let’s get to know…

Lucia Beltran Camacho, 22 years old, born in Tarifa (Cadiz). Degree at Biotechnology by Cadiz University.
 

 

 

-When you were a child, what did you want to be as an adult?
I have always loved everything related to music so I wanted to be a music teacher.
-What do you like the most about your job?
Learning and finding out new things every day.
-What are your future challenges?
Carrying on learning and progressing in order to work as a researcher.
-Your favourite dish
Lasagne.
-A place
Any beach.
-A film
‘Amelie’ ,by Jean-Pierre Jeunet.
-A historical figure
Rosalind Franklin.
-A book
‘The Silver Linings Playbook’, by Matthew Quick.
-A song
‘La piedra invisible’, by Izal.
-What do you usually do in your free time?
I like going to the cinema and spending time with my family and friends. If I have enough time, I love travelling and knowing new places.
-You can’t live without…
Chocolate.
-How do you imagine the world in 20 years?
A world where Science is more important than now and people bet on the progresses that it can offer.

Lucia has been doing a Lab Technician internship at Bionaturis since July, 2016.

Biobide takes part in a research about Malaria funded by Melinda
and Bill Gates

Biobide (Bionaturis Group) has recently participated in a drug discovery research against malaria, a disease that causes about 440,000 deaths each year worldwide. The collaborative international project supported by Melinda and Bill Gates has the main goal of going from Hits to Leads among a selection of 400 compounds –included in the Malaria Box- to which researchers from 30 different countries have had access in the latest two years. The final end is public institutions […]

August 9th, 2016|Blog english|Comments Off|

Biobide takes part in a research about Malaria funded by Melinda and Bill Gates

Biobide (Bionaturis Group) has recently participated in a drug discovery research against malaria, a disease that causes about 440,000 deaths each year worldwide. The collaborative international project supported by Melinda and Bill Gates has the main goal of going from Hits to Leads among a selection of 400 compounds –included in the Malaria Box- to which researchers from 30 different countries have had access in the lastest two years. The final end is public institutions and the industry sharing more open knowledge in order to progress in new joint developments.

The promising results have just been published in a scientific paper and include the toxicity assays in zebrafish performed by Biobide to test the potential toxicity of the candidates to fight malaria. “Our presence in this study shows the versatility and usefulness of the zebrafish as animal model for drug discovery, as well as our expertise in this field. In addition to the obvious scientific value, this collaborative project has also a very relevant social value for Biobide, that is contributing in this way to find solutions for a disease that affected 95 countries worldwide in 2015”, the R&D Management Director at Biobide, Arantza Muriana, has stated.

In the 290 assays made by the different researchers for this study, 130 compounds have shown potential action against malaria which paves the way for a future election of the most suitable ones to develop new drugs. Additionally, some of these compounds have also shown outstanding activity against other disease agents, including bacteria, fungi, other parasites and even human cancer cells. In fact, these positive results have ignited over 30 drug development program devoted to fight different diseases. This initiative has been so satisfying that promoters are already repeating […]

August 2nd, 2016|Blog english|Comments Off|

July Newsletter

If you want to know Bionaturis Group latest news, here you are our July Newsletter

IN THIS ISSUE

Miriam Bastida, ZIP Solutions: “We want to grow and gain international position with Bionaturis Group”

 

Bionaturis debates about the potentiality of the Biotech sector in Andalusia

Let’s get to know…

Nuria Martinez Mas, born in Manresa, PhD at Organic Chemistry and Biochemistry by Ramon Llull University in Barcelona.
 

 

 

-When you were a child, what did you want to be as an adult?
A doctor, but seeing blood, although it is not mine, makes me feel very nervous. Because of that I had to change my calling!
-What do you like the most about your job?
It lets me learn something new every day.
-What are your future challenges?
I would like to know more about patents. It is a very complex field and it is not my proposal becoming an expert but I think that in my current position I need more knowledge because it can influence in the commercial strategy of the company and therefore in the projects we are working on.
-Your favourite dish
I prefer simple dishes. I enjoy a lot with bread, tomato and a good iberian ham.
-A place
The National Park of Aigüestortes, in the Pyrenees.
-A film
‘Life is beautiful’, by Roberto Benigni.
-A historical figure
Marie Curie, a guide for all the women who work in science.
-A book
Anything by Jo Nesbo, a Norwegian writer of crime novels.
-A song
‘Al mar’, by Manel, a catalan band.
-What do you usually do in your free time?
Free time? What is that? With a one-year-old baby, I do not have much! But when it is possible, I like going with my partner to climb 3,000 metre mountains.
-You can’t live without…
The light of the sun, it is vital to have energy and good mood.
-How […]

July 13th, 2016|Blog english|Comments Off|

Miriam Bastida, ZIP Solutions: “We want to grow and gain international position with Bionaturis Group”

Bionaturis Group continues increasing its high-quality products and services offer for human and animal health in its national and international expansion signing collaboration agreements with third relevant parties, creating new subsidiaries in strategic markets and integrating new companies in its structure by M&A transactions. The latest acquisition of Bionaturis Group is Zera Intein Protein Solutions, ZIP Solutions, an international cutting-edge company well known by its industrial solutions for the expression and purification of biological products, one of the highest growing fields in the Health sector. ZIP’s General Manager, Miriam Bastida, stands out the potentialities of the company and its goals in this new stage.

-What is the speciality of ZIP Solutions?

ZIP Solutions is a biotechnological company devoted to develop and commercialise innovative solutions for industrial and pharmaceutical applications. The company has an in-depth knowledge of the requirements of the human and animal health industry, and offers its proprietary solutions, Zera® and Splittera, as differentiating and highly competitive tools to meet their demanding needs. These solutions, having a wide range of applications, are able to produce, for example, biological products that could turn into first in class vaccines and industrial enzymes (in the case of Zera®), also being part of effective cancer treatments as conjugated antibodies (ADCS) or the standardization of diagnosis kits (Splittera). Besides, Splittera offers a solution for an underserved need within the lucrative sector of biodrugs such as its industrial downstream purification. It is worth noting that nowadays biodrugs, with a global market of $165 billion and a double-digit growth rate, are the top runners of the rankings leading, for instance the top sales worldwide –Humira, by Abbvie, with $14 billion annual sales- or the top-five list on oncological products. Its growth continues […]

July 12th, 2016|Blog english|Comments Off|

Bionaturis Group shows its premium solutions for human and animal health to the Bio International Convention 2016

The Bio International Convention 2016 once again will be an essential meeting point in the Bionaturis Group schedule. This event, considered the most important in the biotech sector worldwide, will be held on 6-9th of June in San Francisco (California).

Bionaturis Group is present at the Bio Convention 2016 after a year in which it has strengthened its positioning in the US market after the signing of a contract between Biobide and the US National Institute of Environmental Health (NIEHS), one of the most prestigious and demanding health institutions in the world. Biobide, the Bionaturis Group company that are experts in the use of the zebrafish model, also founded a subsidiary in Maryland in the same year.

In addition, Bionaturis will also highlight at the Bio Convention 2016 the new premium solutions in its portfolio which includes six new developments, five of which are for animal health.  These new developments point to several high-relevance diseases in livestock and pets, such as atopic dermatitis, osteoarthritis (or arthrosis) and different types of cancer. The global Animal Health sector represented an annual figure of $100 billion in 2014. In this area, drugs and vaccines reach until $23 billion (USD) with a CAGR of 6% for 2013-2017.

Bionaturis Group delegates in this edition are the chief scientific officer in Bionaturis, Juan J. Infante, the general Manager of Biobide, Andoni Cruz, and the Global Sales Manager in Bionaturis Group, Eli Kehrli. Biobide’s booth is in the Biobosque Region, inside the Spanish Pavillion (Booth 605). The applications of one-to-one meetings with Bionaturis Group delegates can be arranged emailing to eli.kehrli@bionaturis.com.

Consolidation and new contacts

The main goals of Bionaturis Group in this worldwide event are focused on the consolidation and monitoring of current customers and […]

June 6th, 2016|Blog english, congress|Comments Off|

Bionaturis Group growth, in the MedCap Forum

Bionaturis Group takes part one more year in the Small and Medium-Size Companies Forum -MedCap-, on May 31st and June 1st in Madrid.

Bionaturis Group CEO, Victor Infante, is the person in charge of presenting the latest milestones achieved by the company, among with we can highlight the establishment of the subsidiary BNT China Biosciences in China, the signing of a contract with the US National Institute of Environmental Health (NIEHS) and the recent acquisition of the company ZIP Solutions, that has signed a co-development and exclusive license agreement with a leading multinational company for the final development and market of Splittera® technology.

Thanks to these latest operations, Bionaturis Group continues positioning as a reference company in its area, through its four companies and two subsidiaries with presence in Europe, USA and Asia. The Group offers premium services and products for human and animal health.

In this edition of the MedCap Forum, Bionaturis Group takes part in both ‘One to One’ meetings and the Discovery Meeting, with a lecturer in the afternoon on May, 31st, available here.

About the MedCap

The 11nd MEDCAP Forum gathers the main Small and Medium Size Companies listed on the Spanish Stock Exchange Market as well as institutional investors, brokers and financial analysts. The program includes both sectorial and general round tables, as well as the possibility of holding ‘One to One’ meetings. The main goal of the event is to stimulate the liquidity and founding of these companies.

About Bionaturis Group

Bionaturis Group offers cutting-edge biotechnological drugs and services for human and animal health. Considered an international benchmark in vaccines research, the biotechnological Group which envisions a global access to health is listed on the Spanish stock exchange for SMEs (ticker BNT). In addition to this […]

May 31st, 2016|Blog english, congress, Hechos Relevantes|Comments Off|

Biobide strengthens its participation in international events

The schedule of Biobide scientists this spring is taken by very relevant international events in the sector. This week, the company acquired by Bionaturis Group and specialized in the use of zebrafish as animal model, presents two scientific posters in the Society of Environmental Toxicology and Chemistry (SETAC) Europe 26th Annual Meeting, 22-26 May 2016, at La Cite in Nantes, France.  Biobide also participates in the conference Measuring Behaviour 2016, hold in Dublin, with the research about the relationship between stress and exposure to light in this animal model.

R&D Management Director at Biobide, Arantza Muriana, will lead the presentation in SETAC 2016 of the posters titled ‘Testing toxicity of graphene oxide in zebrafish embryos’ and ‘Toxicity Profiling of Flame Retardants in Zebrafish’, both using zebrafish as animal model for varied toxicity and efficacy assays. The first one addresses the study of toxicity of graphene oxide, a very common material to produce goods used in our daily life, while the second one tackles the study of teratogenicity (possibilities of malformation in the development of the fetus in pregnant women), cardiotoxicity, hepatotoxicity and behavioral alterations in some flame retardants compounds found in everyday household products, to which people are regularly exposed. 

In addition to the presentation of these posters, Arantza Muriana and the Study Director, Virginia Caballero, will respond the large number of applications for one-to-one meetings in this event, considered the most important one in this specialized area in Europe. More than 2,000 scientists from 60 different countries will attend this event addressing relevant topics such as the climate change and contaminants or the production of cosmetics, among others.

Behaviour analysis

At the same time, Biobide takes part this week in the conference Measuring Behaviour 2016, considered the main […]

May 25th, 2016|Blog english, congress|Comments Off|

Bionaturis takes part in the Innovation Forum of La Rioja

Bionaturis chief scientific officer, Dr. Juan Jose Infante, will participate as one of the lecturers in La Rioja’s Innovation Forum. The meeting will be celebrated in the Exhibition and Conference Center of La Rioja the next May 17-18th. Dr. Infante will be lecturing in the ‘Talk Show’ entitled “Bioeconomy and Agro-Food Sector” along with other three experts in this area.

Juan Jose Infante is Phd at Sciences and combines his work leading the development of biological products in Bionaturis with teaching Biotechnology in the Pablo de Olavide University of Seville. He joined Bionaturis in 2007, after a period as senior scientist in the University of Washington in Seattle, USA. In Bionaturis, Dr. Infante has been the principal investigator in the laboratory that developed Bionaturis’ proprietary FLYLIFE platform for manufacturing of biological medicines.

In the previous nine editions, this event has gathered 300 lecturers and more than 7,500 attendants. In this year’s edition, it will address key topics such as alliances of strategic sectors of the Bioeconomy like Food and Agriculture, the reduction of the environmental impact of companies, and potentiation of food control and safety procedures.

Dr. Infante will represent Bionaturis Group, including the matrix company Bionaturis and Biobide and ZIP Solutions. As a general topic, Dr. Infante will address the contribution of the biotech companies in the consolidation of Bioeconomy as a key sector of development. Regarding the Agro-Food, he will review the experience of Bionaturis in developing bio-based innovative solutions for increasing livestock productivity by using preventive measures and immunomodulators, which will lead to a decrease in the use of antibiotics in this sector. Antibiotic resistance has become a serious global health problem. According to the World Health Organization, this situation causes 300,000 deaths every […]

May 12th, 2016|Blog english, congress|Comments Off|

May Newsletter

If you want to know Bionaturis Group latest news, here you are our May Newsletter

IN THIS ISSUE

Bionaturis Group grows through the acquisition of the company ZIP Solutions

Biobide visits Bionaturis facilities

Bionaturis Group increases recurring sales 21.7%, keeping a CAGR of 24.1% on net sales between 2012 and 2015

Let’s get to know…

Alberto Luis Perez Gomez, 22 years old, born in San Fernando (Cadiz). He is nowadays finishing the Degree in Biotechnology at Cadiz University.
 

 

-When you were a child, what did you want to be as an adult?
A bus driver.
-What do you like the most about your job?
Investing my time in something I like and having the opportunity of being in a constant training to evolve.
-What are your future challenges?
Going into detail about knowledge areas such as Genetic Engineering and Molecular Biology and improving my English and French levels.
-Your favourite dish
Cannellone stuffed with tuna.
-A place
Pamukkale (Turquía).
-A film
‘Inception’, by Christopher Nolan.
-A historical figure
Sigmund Freud.
-A book
‘Brave New World’, by Aldous Huxley.
-A song
‘Somebody that I used to know’, by Gotye y Kimbra.
-What do you usually do in your free time?
Swimming, cooking, reading, listening to music and enjoying with my family and friends.
-You can’t live without…
The beach.
-How do you imagine the world in 20 years?
A world with a more conscious and responsible society with its environment, in which Science will walk always hand in hand with progress and nature.

Alberto has been working at Bionaturis as a laboratory technician since July, 2015.

Bionaturis Group grows through the acquisition of
the company ZIP Solutions

Bionaturis Group continues its expansion with the acquisition of the company Zera Intein Protein Solutions (ZIP), specialized in the development of technology for the production of peptides and recombinant proteins for application in the biotechnology, pharmaceutical, veterinary, and industrial sectors. Both […]

May 10th, 2016|Blog english|Comments Off|

April Newsletter

If you want to know Bionaturis Group latest news, here you are our April Newsletter

 

IN THIS ISSUE

Bionaturis Group attends In-cosmetics in Paris

 

Students of the Master in Advanced Biology at Seville University visit Bionaturis

 

Biobide coordinates a course on zebrafish in the conference of the Society of Toxicology (SOT) in New Orleans

Let’s get to know…

Maria Virginia Caballero, born in Granada. PhD at Sciences by Universidad Complutense in Madrid.
 

 

 

-When you were a child, what did you want to be as an adult?
A doctor or a scientist. Although the streak of hairdresser was there, I have always had scientific inquisitiveness and, finally, the Science won.
-What do you like the most about your job?
Being able to find something that could help our society in some way.
-What are your future challenges?
There is no harm in asking… I would love to run a company.
-Your favourite dish
It depends on the day. If we talk about Spanish dishes, black rice; Japanese, Sushi; Italian, Parmigiana… I love eating and it is very difficult to choose only one.
-A place
The sightseeing of La Alhambra from San Cristobal.
-A film
‘The Passion of The Chirst’. It was very impressive for me.
-A historical figure
Mariana Pineda, a very strong and brave woman.
-A book
‘Like water for chocolate’, by Laura Esquivel.
-A song
‘Fado’, by Carlos Cano.
-What do you usually do in your free time?
As many things as I can: practising sports, painting, walking, singing… I love arts, in general.
-You can’t live without…
Music. I always go to bed listening to music and the fist thing I do every morning is switching the music on.
-How do you imagine the world in 20 years?
Better, undoubtedly.

Virginia is working at Biobide (Bionaturis Group) as a Study Director.

Bionaturis Group attends In-cosmetics in Paris

Biobide, part of Bionaturis Group, is attending this […]

April 12th, 2016|Blog english|Comments Off|

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR